Navigation Links
YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS
Date:11/11/2009

September 30, 2009 2008 ------------------------------------------------------------------------- (Unaudited) Out-licensing revenue $ 727,538 $ 1,214,945 Interest income 19,119 442,621 ------------------------------------------------------------------------- 746,657 1,657,566 Expenses: Licensing and product development 2,436,048 3,845,184 General and administrative 1,784,432 1,147,378 ----------------------------------------------------------------------- 4,220,480 4,992,562 ------------------------------------------------------------------------- Loss before the undernoted (3,473,823) (3,334,996) Gain (loss) on foreign exchange (26,747) 12,203 Loss on short-term deposits (2,218) (140,559) Other income - 307,140 ------------------------------------------------------------------------- Loss and comprehensive loss for the period (3,502,788) (3,156,212) Deficit, beginning of period (146,251,951) (133,182,485) ------------------------------------------------------------------------- Deficit, end of period $(149,754,739) $(136,338,697) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Basic and diluted loss per common share $ (0.06) $ (0.06) -------------------------------
'/>"/>
SOURCE YM BioSciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
6. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
7. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
8. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
11. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 29, 2015  AACC, a global scientific and ... laboratory medicine, is pleased to announce that the ... , has increased to 7.9 in the 2014 ... Clinical Chemistry in the top 3% ... influence of the research it publishes on laboratory ...
(Date:6/29/2015)... According to a new market research ... (Diagnostics, Therapeutics, R&D), by Technology (SELEX, Other Technologies), by End ... Global Forecast to 2020", published by MarketsandMarkets, the global Aptamers ... $107.56 Million in 2015, at a CAGR of 17.89%. ... F igures spread through 125 ...
(Date:6/29/2015)... --  For the seventh year running, Across Health conducted a ... maturity called the Multichannel Maturometer . The research ... fast enough. While it,s true that technology is indeed ... customers are increasingly "digital natives", pharma still lags behind ... Logo ...
(Date:6/26/2015)... CITY, Kan. , June 26, 2015 ... PETX ), a pet therapeutics company ... of innovative biopharmaceutical products for companion animals, ... field effectiveness study of capromorelin (AT-002), the ... dogs.  Capromorelin is a small molecule that ...
Breaking Biology Technology:AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 2AACC's Journal, Clinical Chemistry, Continues to Have Significant Impact on Medical Testing, Healthcare 3Aptamers Market Worth $244.93 Million by 2020 2Aptamers Market Worth $244.93 Million by 2020 3Aptamers Market Worth $244.93 Million by 2020 4Results from Digital Maturity Study Show Pharma Lagging 2Results from Digital Maturity Study Show Pharma Lagging 3Results from Digital Maturity Study Show Pharma Lagging 4Aratana Therapeutics Announces Positive Pivotal Results for AT-002 2Aratana Therapeutics Announces Positive Pivotal Results for AT-002 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 4Aratana Therapeutics Announces Positive Pivotal Results for AT-002 5
... , CRANBURY, N.J., Sept. 3 Palatin Technologies, ... will present at the Rodman & Renshaw 11(th) Annual Global Investment ... The conference is being held at the New York Palace Hotel, ... President and Chief Executive Officer of Palatin Technologies, will provide an ...
... Yeng Ming, 35, a lecturer with the School of Materials ... been awarded one of the three inaugural L,Oral Singapore for ... Lam and the two other women scientists have each won ... of women scientists to the advancement of science and research ...
... COLUMBIA, Md., Sept. 2 ACell, Inc. is announcing ... , , The conference will be held ... Palace Hotel in New York City. James DeFrancesco, Chief Executive Officer ... 11th beginning at 9:10 AM (EDT) in the Hubbard Room. The ...
Cached Biology Technology:NTU professor bags inaugural award honoring women in science 2NTU professor bags inaugural award honoring women in science 3ACell's CEO to Present at Rodman & Renshaw's 2009 Annual Global Investment Conference 2
(Date:6/25/2015)... 25, 2015  Imagine a tool specifically designed to ... happier life. That,s exactly what USANA,s True Health ... cutting-edge, portable health program provides a personalized approached to ... improve your lifestyle and nutrition. At ... Wednesday night, USANA,s THA was honored with the Industry ...
(Date:6/24/2015)... , June 24, 2015 The biologics ... The major drivers for the market include growth of ... of new drug launches. Over the years, the number ... Between 2001 and 2010, the FDA approved 225 drug ... to WIPO, Europe accounted for ...
(Date:6/24/2015)... , June 24, 2015  Synaptics Inc. ... human interface solutions, today announced that Sharp has ... provide secure authentication for its latest flagship smartphone ... more than 200 million shipments of its fingerprint ... reinforces Synaptics, strength, scalability and leadership in the ...
Breaking Biology News(10 mins):@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... and other genetic techniques led by Adelaide researchers are ... with destroying protected rainforests. DNA fingerprinting for timber ... led by the University of Adelaide that ... forests where they came from. Professor Andrew Lowe, ...
... nicotine receptors are only important to smokers trying to ... in the FASEB Journal ( http://www.fasebj.org ) ... in social interaction and the ability to choose between ... nicotinic receptors in the prefrontal cortex are essential for ...
... the new generation of ExPASy, a web portal which ... bioinformatics resources. Until now, ExPASy was known as a proteomics-dedicated ... this resource was the first website available for the biomedical ... websites as a whole. Eighteen years later, ExPASy is still ...
Cached Biology News:Using DNA in fight against illegal logging 2Your brain on nicotine: Nicotine receptors affect social behavior 2SIB launches next generation ExPASy, an entry portal to indispensable bioinformatics resources 2
S-100A10 (H-80)...
Vapor phase risers are available in various heights to accomodate a variety of inventory solutions. Risers are used to creat a false bottom in which the tanks platform rests and Liquid nitrogen is s...
... degrades single-stranded DNA and RNA endonucleolytically ... acids (DNA:DNA, DNA:RNA or RNA:RNA) are ... high concentrations of enzyme (1). The ... termini from double-stranded DNA (2), for ...
SP6 RNA Polymerase, 50 l, 20 U/l ,Cap Scribe Buffer, 100 l, 5x conc....
Biology Products: